Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723668 | SCV000111147 | uncertain significance | not provided | 2013-08-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082734 | SCV000285585 | benign | Long QT syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000250456 | SCV000320376 | likely benign | Cardiovascular phenotype | 2015-11-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000079277 | SCV000515665 | benign | not specified | 2015-04-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV003925043 | SCV004745883 | likely benign | CACNA1C-related disorder | 2019-04-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Ce |
RCV000723668 | SCV005092988 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4, BP7, BS1 |